C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat

Diabetologia

Volumn 44, Issue 7, 2001, Pages 889-897

  Sima, A A F ^a   Zhang, W ^a   Sugimoto, K ^a   Henry, D ^a   Li, Z ^a   Wahren, J ^a   Grunberger, G ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

C peptide; Diabetic neuropathy; Morphometry; Na+ K+ ATPase; Nerve conduction velocity

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM); C PEPTIDE; ISOPHANE INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; DEMYELINATION; DIABETIC NEUROPATHY; DRUG EFFECT; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NERVE CONDUCTION; NERVE FIBER DEGENERATION; NERVE FIBER REGENERATION; NEUROPROTECTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN;

ANIMALS; AXONS; C-PEPTIDE; DIABETES MELLITUS, TYPE 1; DIABETIC NEUROPATHIES; DISEASE MODELS, ANIMAL; MALE; MYELIN SHEATH; NERVE REGENERATION; NEURAL CONDUCTION; RATS; RATS, INBRED BB; TIME FACTORS;

EID: 0034945790     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250100570     Document Type: Article

References (47)

1. Aldose reductase inhibitors: An approach to the treatment of the nerve damage of diabetic neuropathy
2. Nerve blood flow and oxygen delivery in normal, diabetic and ischemic neuropathy
3. The linked roles of nitric oxide, aldose reductase and (Na +/K +)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat
4. The primary preventional and secondary interventative effects of acetyl-L-carnitine on diabetic neuropathy in the BB/W-rat
5. Neurotrophism in diabetic neuropathy
6. Type-1 insulin-like growth factor receptor activation regulates apoptotic proteins
7. Studies in animal models on the role of glycation and advanced glycation end-products (AGE's) in the pathogenesis of diabetic complications
8. Effects of DL-α-lipoic acid on peripheral conduction, blood flow, energy metabolism and oxidative stress in experimental diabetic neuropathy
9. Oxidative stress and abnormal lipid metabolism in diabetic complications
10. Experimental diabetic neuropathy: An update
11. The effect of intensive treatment of diabetes on development and progression of long-term complications in insulin-dependent diabetes mellitus
12. Different neuropathic patterns between type I and type II animal models
13. A comparison of diabetic polyneuropathy in type II diabetic BBZDR/Wor-rats and type I diabetic BB/Wor-rats
14. Histopathological heterogeneity of neuropathy in insulin-dependent and non-insulin-dependent diabetes, and demonstration of axo-glial dysjunction in human diabetic neuropathy
15. "Axo-glial dysjunction": A novel structural lesion that accounts for poorly reversible slowing of nerve conduction in the spontaneously diabetic BB-rat
16. Risk factors for severity of diabetic polyneuropathy
17. Effects of insulin and insulin-like growth factors on neurofilament mRNA and tubulin mRNA content in human neuroblastoma SH-Y5Y cells
18. Prevention of vascular and neural dysfunction in diabetic rats by C-peptide
19. C-peptide improves autonomic nerve function in patients with Type I diabetes
20. Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with Type I diabetes - A three month study
21. Aldose reductase gene expression and osmotic dysregulation in cultured human retinal pigment epithelial cells
22. An orderly development of paranodal axoglial junctions and bracelets of Nageotte in the rat sural nerve
23. Insulin biosynthesis: Evidence for a precursor
24. + ATPase activity in synergism with neuropeptide Y
25. Role of C-peptide in human physiology
26. Specific binding of proinsulin C-peptide to human cell membranes
27. C-peptide attenuates protein tyrosine phosphatase activity and enhances glycogen synthesis in L6 myoblasts
28. Changes in nodal function in nerve fibers of the spontaneously diabetic BB-Wistar rat
29. Reversible diabetic nerve dysfunction. Structural correlates to electrophysiological abnormalities
30. Nerve ischemia in diabetic rats: Time course of development, effect of insulin treatment plus comparison of streptozotocin and BB models
31. C-peptide induces concentration-dependent dilation of skeletal muscle arterioles only in the presence of insulin
32. Preventive effect of long-term aldose reductase inhibition (Ponalrestat) on nerve conduction and sural nerve structure in the spontaneously diabetic BB-rat
33. Insulin receptor in rat peripheral nerve: Its localization and alternatively spliced isoforms
34. Ankyrin G: A new ankyrin gene with neural-specific isoforms localized at the axonal initial segment and node of Ranvier
35. The axonal membrane protein Caspr, a homologue of neurexin IV, is a component of the septate-like paranodal junctions that assemble during myelination
36. +-channels
37. Identification of a novel contactin-associated transmembrane receptor with multiple domains implicated in protein-protein interactions
38. + channel displacement is associated with nerve conduction slowing in the chronically diabetic BB/W-rat. Prevention by an aldose reductase inhibitor
39. Insulin-like growth factors protect against diabetic neuropathy: Effects on sensory nerve regeneration in rats
40. Reduced nerve growth factor mRNA in skin of diabetic rats: Effects of insulin
41. Influence of nerve growth factor on neurofilament gene expression in mature primary sensory neurons
42. Effect of insulin and insulin-like growth factors on neurofilament mRNA and tubulin mRNA content in human neuroblastoma SH-Y5Y cells
43. Reduced myelinated fiber size correlates with loss of axonal neurofilaments in peripheral nerve of chronically streptozotocin diabetic rats
44. Lesion-induced increase in nerve growth factor mRNA is mediated by c-fos
45. Impaired macrophage recruitment in axotomized diabetic nerve
46. Nerve fiber regeneration following axotomy in the diabetic BB/W-rat. The effect of ARI treatment